CD274 and neoplasm: The intelligent modular DNA LYTAC (IMTAC) nanostructure was modified with anti‐EGFR and anti‐PD‐L1 antibodies, both individually, and then in combination.[81] The combination demonstrated marked cell death and improved tumor growth inhibition over the monofunctionalized version.